Cellular responses to combinations of hyperthermia and radiation - PubMed (original) (raw)
Review
. 1977 May;123(2):463-74.
doi: 10.1148/123.2.463.
- PMID: 322205
- DOI: 10.1148/123.2.463
Review
Cellular responses to combinations of hyperthermia and radiation
W C Dewey et al. Radiology. 1977 May.
Abstract
The two principal rationales for applying hyperthermia in cancer therapy are that: (a) the S phase, which is relatively radioresistant, is the most sensitive phase to hyperthermia, and can be selectively radiosensitized by combining hyperthermia with x-irradiation; the cycling tumor cells in S phase which would normally survive an x-ray dose could thus be killed by subjecting these cells to hyperthermia; and (b) the relatively radioresistant hypoxic cells in the tumor may be selectively destroyed by combinations of hyperthermia and x-irradiation. Both of these rationales have been mentioned as reasons for using high LET irradiation in cancer therapy; therefore where such irradiation may be of use, hyperthermia may also be advantageous.
Similar articles
- Prospects for hyperthermia in human cancer therapy. Part II: implications of biological and physical data for applications of hyperthermia to man.
Connor WG, Gerner EW, Miller RC, Boone ML. Connor WG, et al. Radiology. 1977 May;123(2):497-503. doi: 10.1148/123.2.497. Radiology. 1977. PMID: 322208 Review. - Response of extremely hypoxic cells to hyperthermia: survival and oxygen enhancement ratios.
Power JA, Harris JW. Power JA, et al. Radiology. 1977 Jun;123(3):767-70. doi: 10.1148/123.3.767. Radiology. 1977. PMID: 860045 - Biological rationale for hyperthermia in cancer treatment (II).
Engin K. Engin K. Neoplasma. 1994;41(5):277-83. Neoplasma. 1994. PMID: 7854498 Review. - The effect of hyperglycemia on the tumor response to irradiation given alone or in combination with hyperthermia.
Urano M, Todoroki T, Kahn J, Okunieff P. Urano M, et al. Radiat Res. 1987 Sep;111(3):488-97. Radiat Res. 1987. PMID: 3659283
Cited by
- Application of Nanoparticles for Magnetic Hyperthermia for Cancer Treatment-The Current State of Knowledge.
Szwed M, Marczak A. Szwed M, et al. Cancers (Basel). 2024 Mar 14;16(6):1156. doi: 10.3390/cancers16061156. Cancers (Basel). 2024. PMID: 38539491 Free PMC article. Review. - Cu3P/1-MT Nanocomposites Potentiated Photothermal-Immunotherapy.
He J, Song R, Xiao F, Wang M, Wen L. He J, et al. Int J Nanomedicine. 2023 Jun 7;18:3021-3033. doi: 10.2147/IJN.S414117. eCollection 2023. Int J Nanomedicine. 2023. PMID: 37312933 Free PMC article. - Combination of Chemotherapy and Mild Hyperthermia Using Targeted Nanoparticles: A Potential Treatment Modality for Breast Cancer.
Kaur I, Tieu T, Deepagan VG, Ali MA, Alsunaydih F, Rudd D, Moghaddam MA, Bourgeois L, Adams TE, Thurecht KJ, Yuce M, Cifuentes-Rius A, Voelcker NH. Kaur I, et al. Pharmaceutics. 2023 Apr 30;15(5):1389. doi: 10.3390/pharmaceutics15051389. Pharmaceutics. 2023. PMID: 37242631 Free PMC article. - Heat promotes melanogenesis by increasing the paracrine effects in keratinocytes via the TRPV3/Ca2+/Hh signaling pathway.
Zhang L, Zeng H, Jiang L, Fu C, Zhang Y, Hu Y, Zhang X, Zhu L, Zhang F, Huang J, Chen J, Zeng Q. Zhang L, et al. iScience. 2023 Apr 26;26(5):106749. doi: 10.1016/j.isci.2023.106749. eCollection 2023 May 19. iScience. 2023. PMID: 37216091 Free PMC article. - Design and Validation of Experimental Setup for Cell Spheroid Radiofrequency-Induced Heating.
Androulakis I, Ferrero R, van Oossanen R, Manzin A, Denkova AG, Djanashvili K, Nadar R, van Rhoon GC. Androulakis I, et al. Sensors (Basel). 2023 May 5;23(9):4514. doi: 10.3390/s23094514. Sensors (Basel). 2023. PMID: 37177718 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources